Rivaroxaban for thromboprophylaxis after hospitalization for medical illness
dc.contributor.author | Spyropoulos, Alex C. | |
dc.contributor.author | Ageno, Walter | |
dc.contributor.author | Albers, Gregory W. | |
dc.contributor.author | Elliott, C. Gregory | |
dc.contributor.author | Halperin, Jonathan L. | |
dc.contributor.author | Hiatt, William R. | |
dc.contributor.author | Maynard, Gregory A. | |
dc.contributor.author | Steg, P. Gabriel | |
dc.contributor.author | Weitz, Jeffrey I. | |
dc.contributor.author | Suh, Eunyoung | |
dc.contributor.author | Spiro, Theodore E. | |
dc.contributor.author | Barnathan, Elliot S. | |
dc.contributor.author | Raskob, Gary E. | |
dc.contributor.author | Jur | |
dc.date.accessioned | 2022-05-31T15:34:08Z | |
dc.date.accessioned | 2023-05-11T17:35:48Z | |
dc.date.available | 2022-05-31T15:34:08Z | |
dc.date.available | 2023-05-11T17:35:48Z | |
dc.date.created | 2018 | |
dc.identifier | https://www.nejm.org/doi/full/10.1056/nejmoa1805090 | |
dc.identifier.issn | 1533-4406 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12032/110563 | |
dc.description.abstract | BACKGROUND Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS In this randomize | |
dc.format | spa | |
dc.format.mimetype | application/pdf | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.title | Rivaroxaban for thromboprophylaxis after hospitalization for medical illness |
Files in this item
Files | Size | Format | View |
---|---|---|---|
a3549.pdf | 377.9Kb | application/pdf | View/ |